<?xml version="1.0" encoding="UTF-8"?>
<ref id="B44">
 <label>44</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Borroni</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Bohrmann</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Grueninger</surname>
    <given-names>F.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Sembragiline: a novel, selective monoamine oxidase type B inhibitor for the treatment of Alzheimerâ€™s disease</article-title>
  <source>
   <italic toggle="yes">The Journal of Pharmacology and Experimental Therapeutics</italic>
  </source>
  <year>2017</year>
  <volume>362</volume>
  <issue>3</issue>
  <fpage>413</fpage>
  <lpage>423</lpage>
  <pub-id pub-id-type="doi">10.1124/jpet.117.241653</pub-id>
  <pub-id pub-id-type="other">2-s2.0-85027534065</pub-id>
  <?supplied-pmid 28642233?>
  <pub-id pub-id-type="pmid">28642233</pub-id>
 </element-citation>
</ref>
